This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Apply straightforward methods to follow a new budget, like trigger-based checks and clear spending rules. These strategies boost adherence over time.
24,213 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Tether rolled out a decentralized local AI initiative linked to its stability framework, calling it a new form of int...
Nvidia and Micron are central to AI data centers, but one may be the better buy for your portfolio. This guide breaks...
As tech’s power demand surges, data centers are becoming a bigger profit driver for utilities, prompting fresh debate...
A former IBM cybersecurity executive alleges repeated foreign breaches on IBM and AT&T networks and claims the compan...
Meta Platforms accelerates its MTIA chip program, signaling a high-stakes race with NVIDIA as hyperscalers push for i...
Costco reports solid membership-driven results in mid-2026, but the stock faces a high bar for growth and valuation. ...
Bed Bath & Beyond reveals a three-pilot strategy to build a housing platform after purchasing Fathom Holdings. The pl...
We examine how wealthy buyers are sustaining housing activity even as the broader market cools for most households. T...
SpaceX sits at the edge of a dramatic valuation leap. This article explores a pivotal contract, the math behind a pos...
As Elanco maps out its path for 2025, investors weigh growth drivers, margins, and catalysts. This guide breaks down ...
Turning Point Brands stock has surged, even as a prominent fund dumped millions in TPB shares. This article breaks do...